PSX
39
4
PG
43
2
EMC
68
26
OXY
41
-3
ROK
40
2
PPL
62
2
ETR
77
-2
TRIP
85
9
MMC
44
-4
D
55
2
CNX
52
-3
COST
57
4
MPC
54
5
UNP
39
-13
ZBH
80
14
MMM
54
2
PLD
41
-5
GE
70
2
FOXA
62
-2
ORLY
45
2
PSX
39
4
PG
43
2
EMC
68
26
OXY
41
-3
ROK
40
2
PPL
62
2
ETR
77
-2
TRIP
85
9
MMC
44
-4
D
55
2
CNX
52
-3
COST
57
4
MPC
54
5
UNP
39
-13
ZBH
80
14
MMM
54
2
PLD
41
-5
GE
70
2
FOXA
62
-2
ORLY
45
2
Financhill
Back

Terns Pharmaceuticals Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
14

TERN
Terns Pharmaceuticals

Last Price:
$4.44
Seasonality Move:
-14.13%
Buy
52

BMRN
Biomarin Pharmaceutical

Last Price:
$61.51
Seasonality Move:
-2.99%
Sell
14
Terns Pharmaceuticals (TERN) is a Sell

Is Terns Pharmaceuticals a Buy, Sell or Hold?

  • The current Terns Pharmaceuticals [TERN] share price is $4.43. The Score for TERN is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • TERN is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
52
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $61.53. The Score for BMRN is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

TERN Stock Price Chart

What is Terns Pharmaceuticals's stock price today?

  • The Terns Pharmaceuticals share price today is $4.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TERN is experiencing selling pressure, which indicates risk of future bearish movement.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $61.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing selling pressure, which indicates risk of future bearish movement.

TERN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.48 Sell
Relative Strength Index (14 RSI): 26.47 Sell
Chaikin Money Flow: -852498 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.95 - 6.39) Sell
Bollinger Bands (100): (5.69 - 8.53) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.87 Sell
Relative Strength Index (14 RSI): 32.71 Sell
Chaikin Money Flow: -1783794 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.88 - 67.6) Sell
Bollinger Bands (100): (62.43 - 78.09) Sell

TERN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.85 Sell
20-day SMA: 5.4 Sell
50-day SMA: 6.08 Sell
200-day SMA: 6.92 Sell
8-day EMA: 4.81 Sell
20-day EMA: 5.32 Sell
50-day EMA: 6.01 Sell
200-day EMA: 6.81 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.85 Sell
20-day SMA: 65.63 Sell
50-day SMA: 65.49 Sell
200-day SMA: 77.22 Sell
8-day EMA: 63.78 Sell
20-day EMA: 65.11 Sell
50-day EMA: 66.54 Sell
200-day EMA: 75.24 Sell

Terns Pharmaceuticals Earnings Growth & TERN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and a decrease next year of $0.07 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.88 per share, and an increase next year of $1.02 per share.

Terns Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):